Hims & Hers Health, Inc.·4

Mar 24, 6:09 PM ET

Okupe Oluyemi 4

4 · Hims & Hers Health, Inc. · Filed Mar 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Hims & Hers (HIMS) CFO Okupe Oluyemi Exercises Options, Sells Shares

What Happened Okupe Oluyemi, Chief Financial Officer of Hims & Hers (HIMS), exercised 4,489 stock options on 2026-03-20 at $5.01 per share (cost ≈ $22,490) and sold 9,217 shares in an open-market transaction for a weighted average price of $23.77, generating proceeds of about $219,067. The filing also reports the conversion/disposition of the 4,489 derivative option units (reported at $0), which is the standard reporting treatment when options are exercised and converted into common shares.

Key Details

  • Transaction date: 2026-03-20; Form 4 filed 2026-03-24 (timely within the two-business-day window).
  • Exercise: 4,489 shares acquired at $5.01 each (total cash paid ≈ $22,490).
  • Sale: 9,217 shares sold at a weighted average price of $23.77 (proceeds ≈ $219,067); individual sale prices ranged $23.73–$23.92.
  • Footnotes: Transaction executed pursuant to a Rule 10b5-1 trading plan adopted May 21, 2025 (F1). Price reported is weighted average; seller can provide per-price breakdown on request (F2). Vesting schedule for options noted in filing (F3).
  • Shares owned after the transactions are not specified in the supplied summary — check the full Form 4 for post-transaction holdings.

Context This filing shows an options exercise paired with open-market sales. The separate reporting of the option conversion (derivative disposed at $0) is normal when options are exercised. The sale was conducted under a pre-established 10b5-1 plan, which is commonly used to execute trades on a preset schedule and is not, by itself, an indicator of the insider’s views.

Insider Transaction Report

Form 4
Period: 2026-03-20
Okupe Oluyemi
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-03-20$5.01/sh+4,489$22,490328,006 total
  • Sale

    Class A Common Stock

    [F1][F2]
    2026-03-20$23.77/sh9,217$219,067318,789 total
  • Exercise/Conversion

    Stock Option (right to buy)

    [F1][F3]
    2026-03-204,489139,562 total
    Exercise: $5.01Exp: 2032-02-23Class A Common Stock (4,489 underlying)
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    7,853
Footnotes (3)
  • [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
  • [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $23.73 - $23.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe|2026-03-24

Documents

1 file
  • 4
    wk-form4_1774390195.xmlPrimary

    FORM 4